- Home
- OFG vs NVCR Comparison
OFG vs NVCR Comparison
Compare OFG & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- NVCR
- Stock Information
- Founded
- OFG 1964
- NVCR 2000
- Country
- OFG United States
- NVCR Switzerland
- Employees
- OFG N/A
- NVCR N/A
- Industry
- OFG Major Banks
- NVCR Medical/Dental Instruments
- Sector
- OFG Finance
- NVCR Health Care
- Exchange
- OFG Nasdaq
- NVCR Nasdaq
- Market Cap
- OFG 1.8B
- NVCR 1.9B
- IPO Year
- OFG N/A
- NVCR 2015
- Fundamental
- Price
- OFG $41.23
- NVCR $17.38
- Analyst Decision
- OFG Buy
- NVCR Buy
- Analyst Count
- OFG 3
- NVCR 6
- Target Price
- OFG $44.00
- NVCR $32.83
- AVG Volume (30 Days)
- OFG 338.8K
- NVCR 834.9K
- Earning Date
- OFG 04-23-2025
- NVCR 04-24-2025
- Dividend Yield
- OFG 2.90%
- NVCR N/A
- EPS Growth
- OFG 6.67
- NVCR N/A
- EPS
- OFG 4.18
- NVCR N/A
- Revenue
- OFG $623,009,000.00
- NVCR $621,711,000.00
- Revenue This Year
- OFG $0.52
- NVCR $2.90
- Revenue Next Year
- OFG $3.97
- NVCR $10.47
- P/E Ratio
- OFG $9.90
- NVCR N/A
- Revenue Growth
- OFG N/A
- NVCR 18.27
- 52 Week Low
- OFG $33.15
- NVCR $14.17
- 52 Week High
- OFG $47.66
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- OFG 63.04
- NVCR 48.17
- Support Level
- OFG $40.32
- NVCR $16.19
- Resistance Level
- OFG $42.24
- NVCR $17.70
- Average True Range (ATR)
- OFG 1.08
- NVCR 0.85
- MACD
- OFG 0.48
- NVCR 0.06
- Stochastic Oscillator
- OFG 85.17
- NVCR 42.53
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.